Characteristics of Cell Lines Established from Human Gastric Carcinoma

Cancer Research

Volumn 50, Issue 9, 1990, Pages 2773-2780

  Park, Jae Gahb ^a,b   Frucht, Harold ^d   LaRocca, Renato V ^c   Bliss, David P ^b   Kurita, Yukio ^b   Chen, Tchaw Ren ^e   Henslee, Jerry G ^f   Trepel, Jane B ^b   Jensen, Robert T ^d   Johnson, Bruce E ^b   Bang, Young Jue ^a   Kim, Jin Pok ^a   Gazdar, Adi F ^b  

^a Seoul National University   (South Korea)

^b NATIONAL NAVAL MEDICAL CENTER   (United States)

^c Vascular Medicine Branch   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AMERICAN TYPE CULTURE COLLECTION   (United States)

^f ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; RADIOISOTOPE; TAG 72 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CYTOCHEMISTRY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; ONCOGENE; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTIGENS, NEOPLASM; CELL LINE; CHROMOSOME ABERRATIONS; GENE AMPLIFICATION; GLYCOPROTEINS; HUMAN; PROTO-ONCOGENES; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0025321564     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Anonymous. Ministry of Health and Social Affairs. One year's report for cancer registry programme in the Republic of Korea. July 1, 1985-June 30, 1986. J. Korean Cancer Assoc., 19: 131–258, 1987.
2. Mettlin, C. Epidemiologic studies in gastric adenocarcinoma. In: H. O. Douglass (ed.), Gastric Cancer, pp, 1–25. New York: Churchill Livingstone, 1988.
3. MacDonald, J. S., Cohn, I., and Gunderson, L. L. Cancer of the stomach. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles and Practice of Oncology, pp. 659–690. Philadelphia: J. B. Lippincott Co., 1985.
4. Romond, E. H., and MacDonald, J. S. Chemotherapy of gastric cancer. In: H. O. Douglass (ed.), Gastric Cancer, pp. 205–220. New York: Churchill Livingston, 1988.
5. Brattain, M. G., Brattain, D. E., Fine, W. D., Khaled, F. M., Marks, M. E., Kimball, P. M., Arcolano, L. A., and Danbury, B. H. Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts. Oncodev. Biol. Med., 2: 355–366, 1982.
6. Park, J. G., Ole, H. K., Sugarbaker, P. H., Henslee, J. G., Chen, T. R., Johnson, B. E., and Gazdar, A. F. Characteristics of cell lines established from human colorectal carcinomas. Cancer Res., 47: 6710–6718, 1987.
7. Willson, J. K. V., Bittner, G. N., Oberley, T. D., Meisner, L. F., and Weese, J. L. Cell culture of human colon adenomas and carcinomas. Cancer Res., 47: 2704–2713, 1987.
8. Hojo, H. Establishment of cultured cell lines of human stomach cancer origin and their morphological characteristics. Niigata Igakukai Zassi, 91: 737–763, 1977.
9. Sekiguchi, M., and Suzuki, T. List of human cell lines established and maintained in Japan. Tissue Culture, 6: 527–548, 1980.
10. Motoyama, T., Hojo, H., and Watanabe, H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol. Jpn., 36: 65–83, 1986.
11. Kubota, H., Harada, T., Morikawa, S., and Nakamura, T. In vivo selection of tumorigenic subline from non-tumorigenic human gastric carcinoma cells: in relation to proliferative properties in vivo and in nude mice. Gastroenterol. Jpn., 23: 371–383, 1988.
12. Whelan, R., Gibby, E., Sheer, D., Povey, S., and Hill, B. T. Characterization of a continuous cell line in culture established from a Km ken berg tumor of the ovary arising from a primary gastric adenocarcinoma. Eur. J. Cancer Clin. Oncol., 24: 1397–1408, 1988.
13. Dobrynin, Y. V. Establishment and characteristics of cell strains from some epithelial tumors of human origin. J. Natl. Cancer Inst., 31: 1173–1195, 1963.
14. Wolff, E. T., and Wolff, E. M. Cultures organotypiques de longue duree de deux tumeurs humaines du tube digestif. Eur. J. Cancer Clin. Oncol., 2: 93–103, 1966.
15. Smith, H. S. In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue. J. Natl. Cancer Inst., 62: 225–230, 1979.
16. Laboisse, C. L., Augeron, C., Couturier-Turpin, M-H., Gespach, C., Cheret, A-M., and Potet, F. Characterization of a newly established human gastric cancer cell line GHT-1 bearing histamine H2-receptors. Cancer Res., 42: 1541–1548, 1982.
17. Barranco, S. C., Townsend, C. M., Jr., Casartelli, C., Macik, B. G., Burger, N. L., Boerwinkle, W. R., and Gourley, W. K. Establishment and characterization of an in vitro system for human adenocarcinoma of the stomach. Clin. Chest Med., 43: 1703–1709, 1983.
18. Lin, C-H., Fu, Z-M., Liu, Y-I., Jang, J-L., Xu, J-F., Chen, O-S., and Chen, H-M. Investigation of SGC-7901 cell line established from human gastric carcinoma cells. Chin. Med. J. (Engl. Ed.), 97: 831–834, 1984.
19. Dippold, W. G., Kron, G., Boosfeld, E., Dienes, H-P., Klingel, R., Knuth, A., Wagner, R., and Buschenfelde, K-H. M. Z. Signet ring stomach cancer: morphological characterization and antigenic profile of newly established cell line (Mz-Sto-1). Eur. J. Cancer Clin. Oncol., 23: 697–706, 1987.
20. Chen, T. R. Rapid trypsin G-band method, Sun et al. modification. Mamm. Chrom. Newsl., 22: 70–71, 1981.
21. Chen, T-R., and Shaw, M. W. Stable chromosome changes in a human malignant melanoma. Cancer Res., 33: 2042–2047, 1973.
22. Baylin, S. B., Stevens, S. A., and Shakir, K. M. Association of diamine oxidase and ornithine decarboxylase with maturing cells in rapidly proliferating epithelium. Biochim. Biophys. Acta, 541: 415–419, 1978.
23. Gazdar, A. F., Helman, L., Israel, M. A., Russell, E. K., Linnolla, I., Mulshine, J., Schuller, H., and Park, J. G. Expression of neuroendocrine cell markers l-DOPA decarboxylase, chromogranin A., and dense core granules in human tumors of endocrine and non-endocrine origin. Cancer Res., 48: 4078–4082, 1988.
24. Collins, M. J., Jr., and Parker, J. C. Murine virus contaminants of leukemia viruses and transplantable tumors. J. Natl. Cancer Inst., 49: 1139–1143, 1972.
25. Harris, H., and Hopkinson, D. A. Handbook of Enzyme Electrophoresis in Human Genetics. New York: North-Holland Publishing Co., 1978.
26. Fletcher, R. H. Carcinoembryonic antigen. Ann. Int. Med., 104: 66–73, 1986.
27. Novis, B. H., Gluck, E., Thomas, P., Steele, G. D., Zurawski, V. R., Jr., Stewart, R., Lavin, P. T., and Zamcheck, N. Serial levels of CA 19–9 and CEA in colon cancer. J. Clin. Oncol., 4: 987–993, 1986.
28. Magnani, J. L., Brockhaus, M., Smith, D. F., Ginsburg, V., Blaszczyk, M., Mitchell, K. F., Steplewski, Z., and Koprowski, H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (Wash. DC), 212: 55–56, 1981.
29. Thor, A., Ohuchi, N., and Schlom, J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res., 46: 3118–3124, 1986.
30. Horan Hand, P., Colcher, D., Salomon, D., Ridge, J., Noguchi, P., and Schlom, J. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Cancer Res., 45: 833–840, 1985.
31. Battey, J., Moulding, C., Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G., and Leder, P. The human c-myc oncogene: structural consequences of translocation in the IgH locus in Burkitt lymphoma. Cell, 34: 779–787, 1983.
32. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., and Trent, J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (Lond.), 305: 245–248, 1983.
33. Nau, M. M., Brooks, B. J., Battey, J., Sausville, E. A., Gazdar, A. F., and Minna, J. D. L-myc: a new mye-related gene amplified and expressed in human small cell lung cancer. Nature (Lond.), 318: 69–73, 1985.
34. Bender, T. P., and Kuehl, W. M. Murine myb protooncogene mRNA: cDNA sequence and evidence for 5′ heterogeneity. Proc. Natl. Acad. Sci. USA, 83: 3204–3208, 1986.
35. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503–517, 1975.
36. Hieter, P. A., Hollis, G. F., Korsmeyer, S. J., Waldmann, T. A., and Leder, P. Clustered arrangement of immunoglobulin lambda constant region genes in man. Nature (Lond.), 294: 536–540, 1981.
37. Jensen, R. T., Moody, T., Pert, C., Rivier, J. E., and Gardner, J. D. Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc. Natl. Acad. Sci. USA, 75: 6139–6143, 1978.
38. Zhou, Z. G., Villanueva, M. L., Noguchi, M., Jones, S. W., Gardner, J. D., and Jensen, R. T. Mechanism of action of calcitonin gene-related peptide in stimulating pancreatic enzyme secretion. Am. J. Physiol., 251: G391-G397, 1986.
39. von Schrenck, T., Heinz-Erian, P., Moran, T., Mantey, S. A., Gardner, J. D., and Jensen, R. T. Characterization of a neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am. J. Physiol., 256: 6747–6758, 1989.
40. Munson, P. J., and Rodbard, D. Ligand characterization of binding systems: a versatile, computerized approach. Anal. Biochem., 107: 220–229, 1980.
41. Stevenson, H., Gazdar, A., Phelps, R., Linnolla, R. I., Ihde, D., Ghosh, B., Woods, E., Ole, H., O'Connor, T., Makuch, R., Kramer, B., and Mulshine, J. Establishment of tumor cell lines in vitro is a negative prognostic factor for survival in non-small cell lung cancer patients. Proc. Am. Soc. Clin. Oncol., 8: 247, 1989.
42. Gazdar, A. F., Carney, D. N., Guccion, J. G., and Baylin, S. B. Small cellcarcinoma of the lung: cellular origin and relationship to other pulmonary tumors. In: F. A. Greco, R. K. Oldham, and P. A. Bunn (eds.), Small Cell Lung Cancer, pp, 145–176. New York: Grune and Stratton, 1981.
43. Barker, P. E. DMs in human tumor cells. Cancer Genet. Cytogenet., 5: 81–94, 1982.
44. Quinn, L. A., Moore, G. E., Morgan, R. T., and Woods, L. K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res., 39: 4914–4924, 1979.
45. Emami, S., Chaske, E., Bodierie, H., Gespach, C., Bataille, D., and Rosselin, G. Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line. Peptides, 7 (Suppl, 1); 121–127, 1986.
46. Bishr Omary, M., and Kagnoff, M. F. Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line. Science (Wash. DC), 238: 1578–1581, 1987.
47. Singh, P., Rae-Venter, B., Townsend, C. M., Jr., Kahalil, T., and Thompson, J. C. Gastrin receptors in normal and malignant gastrointestinal mucosa: age associated changes. Am. J. Physiol., 249: G761-G769, 1985.
48. Weinstock, J., and Baldwin, G. S. Binding of gastrin (17) to human gastric carcinoma cell lines. Cancer Res., 48: 932–937, 1988.
49. Gardner, J. D., and Jensen, R. T. Secretagogue receptors on pancreatic acinar cells. In: L. R. Johnson (ed.), Physiology of the Gastrointestinal Tract, pp, 1190–1127. New York: Raven Press, 1987.
50. Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., and Minna, J. D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (Lond.), 306: 194–196, 1983.
51. Nakasato, F., Sakamoto, H., Mori, M., Hayashi, K., Shimosato, Y., Nishi, M., Takao, S., Nakatani, K., Terada, M., and Sugimura, T. Amplification of the c-myc oncogene in human stomach cancers. Gann, 75: 737–742, 1984.
52. Shibuya, M., Yokota, J., and Ueyama, Y. Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol. Cell. Biol., 5: 414–418, 1985.
53. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature (Lond.), 319: 230–234, 1986.
54. Sakamoto, H., Mori, M., Taira, M., Yoshida, T., Matsukawa, S., Shimizu, K., Sekiguchi, M., Terada, M., and Sugimura, T. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc. Natl. Acad. Sci. USA, 83: 3997–4001, 1986.
55. Yoshida, M. C., Wada, M., Satoh, H., and Yoshida, T. Human HST1 (HSTF1) gene maps to chromosome band Hql3 and coamplifies with the INT2 gene in human cancer. Proc. Natl. Acad. Sci. USA, 85: 4861–4864, 1988.
56. Ohuchi, N., Horan Hand, P., Merlo, G., Fujita, J., Mariani-Constantini, R., Thor, A., Nose, M., Callahan, R., and Schlom, J. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Cancer Res., 47: 1413–1420, 1987.
57. O'Hara, B. M., Oskarsson, M., Tainsky, M., and Blair, D. G. Mechanism of activation of human ras genes cloned from a gastric adenocarcinoma and a pancreatic carcinoma cell line. Cancer Res., 46: 4695–4700, 1986.
58. Bos, J. L., Veriaan-de Vries, M., Marshall, C. J., Veeneman, G. H., Van Boom, J. H., and Van der Eb, A. J. A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res., 12: 1209–1217, 1986.
59. Park, J. G., Kramer, B. S., Lai, S. L., Goldstein, L. J., and Gazdar, A. F. Chemosensitivity patterns and expression of human multidrug resistance (MDR1) gene by human gastric and colorectal cell lines. J. Natl. Cancer Inst., 82: 193–198, 1990.
60. Frucht, H., Oie, H. K., Park, J. G., Gazdar, A. F., Gardner, J. D., and Jensen, R. T. Presence of peptide receptors on newly established human colon cancer cell lines. Gastroenterology, 96: A161, 1989.